Trimel Pharmaceuticals specializes in the development of medications for female sexual health and conditions associated with aging and wellbeing. The company is currently developing multiple product opportunities, including CompleoTRT, which is a bio-adhesive intranasal testosterone gel presently in Phase III clinical testing in the U.S. CompleoTRT is under investigation for the treatment of male hypogonadism, commonly referred to as “Low T.” For more information, visit the company’s Web site at www.trimelpharmaceuticals.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: